Hung-Yi Li

Title: Innovations and Contributions of Inventor Hung-Yi Li

Introduction

Hung-Yi Li is a notable inventor based in Xinying, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of protein fragments and biomarkers associated with liver fibrosis. With a total of 5 patents, his work has the potential to impact clinical practices and improve patient outcomes.

Latest Patents

One of Hung-Yi Li's latest patents is a method of detecting a urine protein fragment and a serum protein fragment. This method describes the detection of specific protein fragments in urine and serum samples obtained from the same individual. The protein fragments include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, and serum osteopontin fragments. Another significant patent focuses on identifying biomarkers useful in liver fibrosis diagnosis. This patent highlights the identification of urokinase-type plasminogen, matrix metalloproteinase 9, and β-2-microglobulin as novel biomarkers associated with liver fibrosis, which can aid in diagnosing and staging the condition.

Career Highlights

Hung-Yi Li has worked with prominent organizations such as the Industrial Technology Research Institute and Bio Preventive Medicine Corporation. His experience in these institutions has allowed him to develop innovative solutions in the medical field.

Collaborations

Hung-Yi Li has collaborated with notable colleagues, including Tzu-Ling Tseng and Yen-Peng Li. Their joint efforts have contributed to advancements in medical diagnostics and research.

Conclusion

Hung-Yi Li's innovative work and patents in the field of medical diagnostics demonstrate his commitment to improving healthcare. His contributions have the potential to enhance the accuracy of disease detection and ultimately benefit patients worldwide.